Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis

Abstract Background A direct link between human immunodeficiency virus (HIV)-infected patients and the risk of cardiovascular diseases (CVD) has been shown in recent scientific research. However, this issue is controversial since other previous reports showed no apparent impact of HIV or its anti-re...

Full description

Bibliographic Details
Main Authors: Pravesh Kumar Bundhun, Manish Pursun, Wei-Qiang Huang
Format: Article
Language:English
Published: BMC 2017-07-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12872-017-0624-0
_version_ 1828383175311622144
author Pravesh Kumar Bundhun
Manish Pursun
Wei-Qiang Huang
author_facet Pravesh Kumar Bundhun
Manish Pursun
Wei-Qiang Huang
author_sort Pravesh Kumar Bundhun
collection DOAJ
description Abstract Background A direct link between human immunodeficiency virus (HIV)-infected patients and the risk of cardiovascular diseases (CVD) has been shown in recent scientific research. However, this issue is controversial since other previous reports showed no apparent impact of HIV or its anti-retroviral drugs on the cardiovascular system. We aimed to systematically compare the postinterventional adverse cardiovascular outcomes which were observed in patients with and without HIV infection during a mean follow up period ranging from 1 year to 3 years. Methods Common electronic databases were searched for studies which compared postinterventional adverse cardiovascular outcomes [mortality, myocardial infarction (MI), cardiac death, target vessel revascularization (TVR), target lesion revascularization (TLR), stroke and major adverse cardiac events (MACEs)] in patients with and without HIV infection. Statistical analysis was carried out by the RevMan 5.3 software whereby Odds Ratios (OR) and 95% Confidence Intervals (CIs) were generated. Results Two thousand two hundred and sixty-eight (2268) patients (821 patients were HIV positive and 1147 patients were HIV negative) were analyzed. The current results showed that mortality was not significantly increased among patients who were HIV positive with OR: 1.13, 95% CI: 0.65–1.96; P = 0.66. Cardiac death was also similarly reported with OR: 1.16, 95% CI: 0.50–2.68; P = 0.74. However, even if recurrent MI, TVR, TLR, MACEs and stroke were higher in patients who were HIV positive, with OR: 1.32, 95% CI: 0.88–2.12; P = 0.18, OR: 1.36, 95% CI: 0.88–2.12; P = 0.17, OR: 1.22, 95% CI: 0.72–2.06; P = 0.46, OR: 1.29, 95% CI: 0.89–1.85; P = 0.17 and OR: 1.47, 95% CI: 0.44–4.89; P = 0.53 respectively, these results were not statistically significant. Conclusion Patients who were infected with HIV had similar mortality post coronary intervention compared to patients who were not infected by the virus, during a mean follow-up period of 1–3 years. In addition, no significant increase in MI, TVR, TLR, MACEs and stroke were observed during this follow up period. Therefore, it might be concluded that no apparent impact of HIV on the cardiovascular outcomes was observed post coronary intervention.
first_indexed 2024-12-10T04:45:18Z
format Article
id doaj.art-49716bebcb16447eaa6f7570cf4de86f
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-12-10T04:45:18Z
publishDate 2017-07-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-49716bebcb16447eaa6f7570cf4de86f2022-12-22T02:01:46ZengBMCBMC Cardiovascular Disorders1471-22612017-07-011711910.1186/s12872-017-0624-0Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysisPravesh Kumar Bundhun0Manish Pursun1Wei-Qiang Huang2Institute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical UniversityGuangxi Medical UniversityInstitute of Cardiovascular Diseases, the First Affiliated Hospital of Guangxi Medical UniversityAbstract Background A direct link between human immunodeficiency virus (HIV)-infected patients and the risk of cardiovascular diseases (CVD) has been shown in recent scientific research. However, this issue is controversial since other previous reports showed no apparent impact of HIV or its anti-retroviral drugs on the cardiovascular system. We aimed to systematically compare the postinterventional adverse cardiovascular outcomes which were observed in patients with and without HIV infection during a mean follow up period ranging from 1 year to 3 years. Methods Common electronic databases were searched for studies which compared postinterventional adverse cardiovascular outcomes [mortality, myocardial infarction (MI), cardiac death, target vessel revascularization (TVR), target lesion revascularization (TLR), stroke and major adverse cardiac events (MACEs)] in patients with and without HIV infection. Statistical analysis was carried out by the RevMan 5.3 software whereby Odds Ratios (OR) and 95% Confidence Intervals (CIs) were generated. Results Two thousand two hundred and sixty-eight (2268) patients (821 patients were HIV positive and 1147 patients were HIV negative) were analyzed. The current results showed that mortality was not significantly increased among patients who were HIV positive with OR: 1.13, 95% CI: 0.65–1.96; P = 0.66. Cardiac death was also similarly reported with OR: 1.16, 95% CI: 0.50–2.68; P = 0.74. However, even if recurrent MI, TVR, TLR, MACEs and stroke were higher in patients who were HIV positive, with OR: 1.32, 95% CI: 0.88–2.12; P = 0.18, OR: 1.36, 95% CI: 0.88–2.12; P = 0.17, OR: 1.22, 95% CI: 0.72–2.06; P = 0.46, OR: 1.29, 95% CI: 0.89–1.85; P = 0.17 and OR: 1.47, 95% CI: 0.44–4.89; P = 0.53 respectively, these results were not statistically significant. Conclusion Patients who were infected with HIV had similar mortality post coronary intervention compared to patients who were not infected by the virus, during a mean follow-up period of 1–3 years. In addition, no significant increase in MI, TVR, TLR, MACEs and stroke were observed during this follow up period. Therefore, it might be concluded that no apparent impact of HIV on the cardiovascular outcomes was observed post coronary intervention.http://link.springer.com/article/10.1186/s12872-017-0624-0Human immunodeficiency virusPercutaneous coronary interventionCardiovascular outcomesAcquired immune deficiency syndromeCoronary artery diseaseHighly active antiretroviral therapy
spellingShingle Pravesh Kumar Bundhun
Manish Pursun
Wei-Qiang Huang
Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis
BMC Cardiovascular Disorders
Human immunodeficiency virus
Percutaneous coronary intervention
Cardiovascular outcomes
Acquired immune deficiency syndrome
Coronary artery disease
Highly active antiretroviral therapy
title Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis
title_full Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis
title_fullStr Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis
title_full_unstemmed Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis
title_short Does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention?: a systematic review and meta-analysis
title_sort does infection with human immunodeficiency virus have any impact on the cardiovascular outcomes following percutaneous coronary intervention a systematic review and meta analysis
topic Human immunodeficiency virus
Percutaneous coronary intervention
Cardiovascular outcomes
Acquired immune deficiency syndrome
Coronary artery disease
Highly active antiretroviral therapy
url http://link.springer.com/article/10.1186/s12872-017-0624-0
work_keys_str_mv AT praveshkumarbundhun doesinfectionwithhumanimmunodeficiencyvirushaveanyimpactonthecardiovascularoutcomesfollowingpercutaneouscoronaryinterventionasystematicreviewandmetaanalysis
AT manishpursun doesinfectionwithhumanimmunodeficiencyvirushaveanyimpactonthecardiovascularoutcomesfollowingpercutaneouscoronaryinterventionasystematicreviewandmetaanalysis
AT weiqianghuang doesinfectionwithhumanimmunodeficiencyvirushaveanyimpactonthecardiovascularoutcomesfollowingpercutaneouscoronaryinterventionasystematicreviewandmetaanalysis